Open AccessFibrinogen as a potential biomarker for clinical phenotype in patients with chronic obstructive pulmonary disease
Author(s) -
Tae Hoon Kim,
Dong Kyu Oh,
YeonMok Oh,
Sei Won Lee,
Sang Do Lee,
Jae Seung Lee
Publication year - 2018
Publication title -
journal of thoracic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.682
H-Index - 60
eISSN - 2077-6624
pISSN - 2072-1439
DOI - 10.21037/jtd.2018.08.52
Subject(s) - fibrinogen , copd , medicine , exacerbation , biomarker , disease , gastroenterology , biochemistry , chemistry
Under the Food and Drug Administration's drug development tool qualification program, fibrinogen is the first biomarker drug development tool used in chronic obstructive pulmonary disease (COPD). However, the correlation between fibrinogen and exacerbations among Korean patients with COPD remains unclear.